Guidance

Why is my baby being offered an RSV immunisation?

This leaflet is for parents of premature babies who are offered Clesrovimab or Nirservimab to help protect their baby against respiratory syncytial virus (RSV).

• From: UK Health Security Agency
• Published: 19 August 2025
• Last updated: 5 August 2026 — See all updates

Documents

Why is my baby being offered an RSV immunisation clesrovimab or nirsevimab?

HTML

Why is my baby being offered an RSV clesrovimab or nirsevimab immunisation (print version)

PDF, 391 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This leaflet is suitable for all parents whose babies are born prematurely and at risk of respiratory syncytial virus (RSV). It describes the:

• signs and symptoms of RSV
• clesrovimab or niservimab injection and how they help to protect against RSV
• side effects and how to report them

You can view, download, or order printed copies of this leaflet for free from Find Public Health Resources using the product code: 1387 447H EN 001

Find public health resources

Find this resource on www.gov.uk/publichealthresources where you can view, download or order resources free of charge.

Alternatively, you can get in touch by phone or email.

Please have the product code with you when you contact us.

Email publichealthresources@ukhsa.gov.uk

Contact form https://www.gov.uk/gui...

Telephone: 0300 123 1002

Monday to Friday, 9am to 5:30pm

Published 19 August 2025

Last updated 5 August 2026 — Show all updates

1. 5 August 2026

   Added new version of leaflet for parents that includes clesrovimab.

2. 27 August 2025

   Added link to order paper copies.

3. 19 August 2025

   First published.